Maintaining the quality of life and social activity of women in the post-reproductive period
Keywords:menopause, life quality, prevention, project
Taking into account the increase in the proportion of women in the post-reproductive age in society and the increase in the retirement age, it becomes necessary to preserve their professional and social activity. As of 2016, in the structure of the female population of Ukraine, women over 50 years are 46.7%, respectively, the number of women over 45 years is more than half. However, today the problems of women of post-reproductive age are paid insufficient attention both by society, and by the media and social organizations.
The issue of maintaining the life quality and social activity of women in the post-reproductive period was discussed on April 5, 2017 in Kiev at an expert council meeting in which leading experts in obstetrics and gynecology, cardiology, family medicine and oncology participated. As noted at the meeting, the relevance of this topic is primarily due to the deterioration of the life quality due to the cessation of ovarian function and the appearance of symptoms of menopause, along with an increase in the incidence of cardiovascular diseases, oncological pathology, and type II diabetes at post-reproductive age.
In this regard, at the meeting of the expert council it was proposed to implement the social and information project “Femininity of the future”, within the framework of which in the next 3 years (2017–2019) in 18 regions of Ukraine a number of measures aimed at preserving the life quality and social activity of women in the post-reproductive period. In particular, among them is the development of methods that reduce the risk of developing diseases, increase the level of knowledge of patients and doctors of different directions on modern approaches to the prevention, diagnosis and treatment of menopausal disorders in women, a large-scale educational program on the preservation of life quality, social activity of women in the post-reproductive period and with respect to methods for reducing the risk of cardiovascular pathology, oncological diseases.
- “National consensus on the management of patients in menopause.” Reproductive endocrinology 1.27 (2016): 8–25.
- Tatarchuk, T.F., Islamova, A.O., Yefіmenko, O.A. “Menopausal syndrome as the first clinical manifestation of perimenopause.” Reproductive endocrinology 1.21 (2015): 2–6.
- Mitchenko, O.I., Romanov, V.U., Iliushina, G.Y. “Cardiovascular risk in patients with hypertension on the background of physiological and post-surgical menopause.” Ukrainian Medical Journal 5.109 (2015).
- Vepopotvelyan, P.N., Tsekhmystrenko, I.S., Vepopotvelyan, N.P. “Preventive salpingectomy – is a necessity or option of a norm?” Health of woman 7.113 (2016).
- Cancer in Ukraine 2016. Bulletin of the National Cancer Register of Ukraine No. 17. Kyiv (2016): 16–17.
- De Angelis, R., et al. “Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5-a population-based study. ” Lancet Oncol 15 (2014): 23–34.
- World Health Organization. Cardiovascular disease (CVDs) (2016). Available from: [http://www.who.int/mediacentre/factsheets/fs317/en/], last accessed Sep 6, 2017.
- Ramachandran, H.J., et al. “Awareness, knowledge and healthy lifestyle behaviors related to coronary heart disease among women: An integrative review.” Heart & Lung 45.3 (2016): 173–85.
- National cancer institute. Surveillance, Epidemiology, and End Results Program. Cancer stat facts: Female breast cancer. Available from: [http://seer.cancer.gov/statfacts/html/breast.html], last accessed Sep 6, 2017.
- Waidyasekera, H., Wijewardena, K., Lindmark, G., Naessen, T. “Menopausal symptoms and quality of life during the menopausal transition in Sri Lankan women.” Menopause 16 (2009): 164–70.
- Schenberg, T. “Prophylactic bilateral salpingectomy as a prevention strategy in women at high risk of ovarian can cer: a mini-review.” Front Oncol 4 (2014): 21.
- Salvador, S., et al. “The fallopian tube: primary site of most pelvic high grade serous carcinomas.” Int J Gynecol Cancer 19.1 (2009): 58–64.
How to Cite
Copyright (c) 2017 В. В. Камінський, Ю. Г. Антипкін, Т. Ф Татарчук
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.